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degenerative disease in which the specialized light-sensitive photoreceptor cells in the eye die, was launched (clinicaltrials. gov # NCT02556736).
The use of optogenetics in the peripheral nervous system (PNS) has to date been relatively modest, however, compared to optogenetic control in the brain (Jeschke and Moser 2015, Montgomery et al 2016) , because of several physiologic and technological challenges. Peripheral nerves are complex, heterogeneous tissues embedded in muscle and connective tissue, which strongly scatter and absorb visible light. Nerves vary significantly in length and diameter, with small visceral nerves 100 times smaller than larger nerves, such as the sciatic nerve. Peripheral nerve stimulation is often conducted in awake, freely moving animals as anesthesia alters nerve excitability properties. Under normal physiologic conditions, peripheral nerves are stretched as joints move and muscles elongate, making consistent light delivery complex. Methods similar to those used in the brain can be used to express opsins in peripheral neurons; however several groups have reported on the difficulties in doing so with sufficient stability and efficacy and without interfering with the regular function of the peripheral neurons (Miyashita et al 2013) .
Controlled and long-term light delivery to peripheral nerves requires advances in neurotechnology to both enable longlasting and efficient opsin expression in specific subsets of axons in peripheral nerves and the production of implantable interfaces biointegrated with the flexible nerves and capable of sufficient light power delivery over extended periods of time without producing nerve damage.
In a pioneer study, Llewellyn et al demonstrated that optical stimulation of motor units in a nerve of a transgenic mouse expressing the light-activated cation channel ChR2 in Thy1 + neurons better approximated physiological recruitment of motor fibers than electrical stimulation (Llewellyn et al 2010) . For the first time, this study presented an optoelectronic implant for optical modulation of the sciatic nerve. However, the stiffness of the hybrid implant hosting 16 millimeter-side light emitting diodes (LEDs) limited its application to acute, anaesthetized conditions only.
Transdermal optical stimulation is a non-invasive alternative approach to optogenetic stimulation of peripheral sensory neurons. Excitation (Daou et al 2013 , Arcourt et al 2017 , Browne et al 2017 and inhibition (Iyer et al 2014 , Daou et al 2016 of mouse primary afferent neurons have been demonstrated using such a design but efficient control of axon activation strongly depends on the optical properties of the intermediate tissues e.g. skin and subcutaneous tissue (Montgomery et al 2016 , Maimon et al 2017 . Effectively, stimulation is limited to nerve terminals in the skin whose superficial epidermal layers are innervated by nociceptors. Direct optical stimulation of nerves using an implant is a promising approach for chronic PNS optogenetics. The question is how best to do this? The rapidly expanding use of optogenetics in the CNS has triggered development of a variety of optoprobes in the form of waveguide, miniaturized optical fibers and optoelectronic µLED-based arrays (Wu et al 2013 , Canales et al 2015 , Fan and Li 2015 , Alt et al 2017 , Iseri and Kuzum 2017 , Pisanello et al 2017 yet very few answer the technical needs for chronic peripheral nerve optogenetics.
Inspired by the report from Towne et al on an optical fiberbased nerve cuff for optical stimulation in freely-behaving rats (Towne et al 2013) , we have constructed a soft and biointegrated optocuff as an optical neural implant for chronic peripheral optogenetic stimulation in freely-behaving mice. The optocuff delivers blue light to axons expressing channelrhodopsin (ChR2) in transgenic mice. We overcame chronic implantation challenges with a miniaturized cuff design with soft materials and motion-compliant optic fibers. We demonstrate optical muscle activation with epineural stimulation of Thy1 expressing motor axons and a stable nerve-implant interface after 20 d in vivo. This optocuff enables broad optogenetic neuromodulation of peripheral axons and is likely to contribute to the evaluation of using this strategy for new therapeutic interventions for the impaired PNS.
Methods

Mice
All mice were purchased from Jackson Laboratories and Thy1-Cre mice were backcrossed to C57BL/6 for at least five generations. Targeted expression of ChR2-tdTomato was achieved by breeding heterozygous Rosa-CAG-LSLhChR2(H134R)-tdTomato-WPRE (Ai27D) mice with Thy1-Cre mice. Resultant Thy1-Cre::ChR2 mice were heterozygous for both transgenes and were housed with control littermates. Mice were given ad libitum access to food and water and were housed in at 22 ± 1 °C, 50% relative humidity, and a 12 h light:12 h dark cycle. Male and female mice were pooled by genotype to limit the number of animals used. All experiments were conducted according to institutional animal care and safety guidelines and with IACUC approval at Boston Children's Hospital, and accordance with Swiss federal legislation and under the guidelines established at EPFL and approved by local Swiss Veterinary Offices.
DRG neuron culture and electrophysiology
Dorsal root ganglia neurons were isolated from adult (3-6 month old) mice and maintained at 37 °C in 5% carbon dioxide. Electrophysiological recordings were made at 20-22 °C up to 24 h after DRG neuron dissociation, using the whole-cell configuration of the patch-clamp technique. Recording pipettes had tip resistances of 4-8 MΩ when filled with (in mM): 135 K-gluconate, 10 KCl, 1 MgCl 2 , 5 EGTA, and 10 HEPES, pH 7.3. The extracellular solution contained (in mM): 145 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 HEPES, and 10 glucose, pH 7.4. All solutions were maintained at 300-315 mOsm l −1 . Membrane potential was recorded in current clamp mode with an Axopatch 200A amplifier and Digidata 1400A A/D interface using pClamp 10.2 software (Molecular Devices). The data were low-pass filtered at 5 kHz (4-pole Bessel filter) and sampled at 10 kHz. Input resistance was typically >500 MΩ, and cells with resistances <200 MΩ were discarded. Care was taken to maintain membrane access resistance as low as possible (usually 3-7 MΩ and always less than 10 MΩ). Detailed methods can be found in Browne et al (2017) .
Nerve optical properties
Sciatic nerves of five naïve adult mice were carefully explanted after CO 2 asphyxiation, immersed in PBS then embedded in 2.5% agarose gel. Cross-sectional slices (100-1000 µm thick) were obtained with a vibratome apparatus (VTS1200, Leica) and mounted on microscopic glass slides (Superfrost, Thermo Scientific). A drop of saline was added to prevent slices from drying. Tissue transmittance was immediately measured with an optical system composed of a photodiode (S170C, Thorlabs), a power meter console (PM100D, Thorlabs) and a 473 nm DPSS laser (100 mW, LaserGlow) coupled to a multimode SMA optic fiber (105 µm core diameter, 1 m length, Thorlabs). The sensor was shaded with a mask matching nerve cross-section dimensions and a constant intensity (15 mW · mm −2 ) illuminated the slices. The light radial distribution in sciatic nerve tissue was finally modeled using the modified 1D Beer-Lambert law:
where I 0 is the optic fiber output irradiance, µ eff the effective attenuation coefficient and z the slice thickness (Al-Juboori et al 2013).
Optocuff construction
The cuff was built upon a polystyrene rod template (0.88 mm diameter, Evergreen). A soft 150 µm thick platinum-catalyzed silicone (Ecoflex 00-50, Smooth-On) was vertically spin-coated and cured (2 h at 80 °C). A gold film was sputtered (80 nm, DP650, Alliance Concept) on the silicone to act as a light reflective coating. Finally, a micrometric film of Polydimethylsiloxane (PDMS) (Sylgard 184, Dow Corning) was used for encapsulation by spray deposition of a PDMSHeptane mixture. A 12 cm optic fiber (FG105UCA, 105 µm inner core diameter Thorlabs) was processed similarly to previous papers (Sparta et al 2011) . Briefly, the acrylate coating tip-end of the fiber was dissolved in acetone and terminated with a 1.25 mm ceramic ferrule (CFLC128, Thorlabs). The fiber was then polished using a dedicated kit (Thorlabs) and its light transmission controlled with a power sensor. The distal end of the fiber was perpendicularly coupled to the cuff template and polymer sealed (Kwik-Sil, World Precision Instruments). Finally, the rod was carefully removed, the cuff trimmed (2 mm length, 0.8 mm inner diameter) and a sharp incision was applied transversally to the cuff. The compressive stress built during elastomer curing caused the cuff to spontaneously fold spirally.
Optocuff implantation
All animal procedures were approved by the institutional animal care and safety guidelines and with IACUC approval at Boston Children's Hospital. Healthy adult (3-6 month old) male and female Thy1-Cre::ChR2 mice of average mass 27.5 g were implanted with the optical cuff. Mice were anesthetized under isoflurane (1-3%) and the body temperature was maintained with a heated surgical table (37 °C). The left hindlimb and head of the mouse were shaved and the skin disinfected using successive applications of betadine and isopropyl alcohol. Under sterile conditions, a skin incision exposed the skull, where 2 precision screws were drilled. The sciatic nerve was exposed at the mid-thigh level after a parallel 1 cm long skin incision and blunt muscles separation. The optical cuff and optic fiber were threaded subcutaneously, the ferrule end laying down the mouse skull and the cuff proximal to the sciatic nerve. A loop was formed on the optic fiber so the cuff has a 90° incidence angle on the sciatic nerve and to relieve the strain along the fiber after implantation. The cuff was then applied to wrap the sciatic nerve and a loose suture secured the optic fiber to surrounding muscles. The separated muscles were sewed back together with absorbable sutures. The ferrule was anchored to the skull with a small amount of dental cement, and the incisions at the head and hindlimb closed with sutures (6-0, Ethicon). Full surgical procedure took 45 min. Control mice used in behavioural experiments underwent similar surgical procedure with the skull and sciatic nerve being exposed. Only a ferrule fixed on a 1 cm long optic fiber was mounted on the skull so blinded experimenters could not distinguish experimental groups. Mice were allowed to recover in single housed cage and subcutaneously injected with post-operative meloxicam analgesic for 3 d.
EMG electrode implantation and data acquisition
All surgical procedures were performed in accordance with Swiss federal legislation and under the guidelines established at EPFL and approved by local Swiss Veterinary Offices. The animals were administered general anesthesia (mixture of 80 mg ml −1 ketamine, 10 mg ml −1 xylazine, diluted in saline), using intraperitoneal injections (8.5 ml kg
−1
). Bipolar intramuscular electrodes (AS632, Cooner Wire) were inserted unilaterally in the tibialis anterior (TA, ankle flexor) muscles to record electromyographic activity. Recording electrodes were created prior to implantation by removing a small part (~200 µm notch) of Teflon insulation. All the wires were connected to a percutaneous amphenol connector (Omnetics Connector Corporation). EMG recordings were synchronized with the laser stimulation onset using a custom-developed Tucker-Davis Technology (TDT) code. Signals were amplified (×1000) and pre-filtered (Bandpass: 100 Hz-1 kHz) with an AM systems amplifier.
Optogenetic control and high-speed behavioural imaging
The optical cuff was coupled to the laser with a multimode FC/PC optic fiber cable (105 µm core diameter, 2 m length, Thorlabs) using a ceramic mating sleeve (ADAL1, Thorlabs) on the ferrule. It was critical avoiding any physical stress on the mouse during the operation. Mice were housed in a small chamber (7.5 × 7.5 × 15 cm 3 ) chambers and acclimatized for at least 30 min. A counter-balance lever arm (Harvard Apparatus) relieved the mouse from the laser optic fiber cable weight. A computer-controlled pulse generator (OPTG-4, Doric) was used to supply TTL signals to the laser driver. Simultaneous epineural optogenetic stimulation (average 40 mW laser output) and high-speed recordings were performed. Behaviour was sampled at 1000 frames per second using an acA2040-180kmNIR cameralink CMOS camera (Basler) with a 8 mm lens and set at 500 pixels × 350 pixels. Acquisition was carried out in LabVIEW on a computer with excess buffer capacity to ensure all frames were successfully retained. Littermate control mice without Cre recombinase and implanted with the optical cuff did not react to blue light pulse (20 ms, 60 mW). Cuff implanted Thy1-Cre::ChR2 mice did not respond to an equivalent off-spectra pulse of light (594 nm, LaserGlow).
Behavioral experiments
All experiments were conducted in a quiet room at 22 ± 1 °C with 50% relative humidity. Animals were acclimatized to the behavioral testing apparatus during three habituation sessions in advance of starting the experiment. The behavioral tester was blinded until the experiment was complete.
2.8.1. Mechanical sensitivity. Mice were habituated, single housed in a small transparent chamber (7.5 × 7.5 × 15 cm 3 ) elevated on a wire grid. Mechanical sensitivity was measured by applying an increasing perpendicular force to the lateral plantar surface of the left hindpaw using graded series of six von Frey filaments (with bending force of 0.04, 0.07, 0.16, 0.4, 0.6, 1 g) and counting the number of withdrawal responses across ten applications. The pain mechanical threshold was defined as the minimal force triggering at least five withdrawals.
Thermal sensitivity.
Each mouse was habituated on a warmed (29 °C) glass platform of a Hargreave's apparatus (IITC Life Science). Thermal sensitivity was determined by applying a radiant heat source to the plantar hindpaw while measuring the duration before hindpaw withdrawal. The latency for the onset of nocifensive behavior was timed. This latency was determined three times per animal, per session, with a 5 min interval to prevent thermal sensitization.
Dynamic weight bearing.
Mice inflammatory pain was assessed using a DWB test (Bioseb). Each mouse was placed 5 min in a Plexiglas chamber (11 × 19.7 × 11 cm 3 ) with a pressure transducers array on the floor. A camera recorded each movement while the mouse was exploring the chamber. Using a software matching pressure data and the video recordings, we discriminated and measured the weight (in grams) applied by the limbs. Finally, we extracted the duration of the cuff implanted hindpaw on the floor over the contralateral one.
Motor sciatic nerve assessment.
Motor recovery in mice was assessed using a DigiGait apparatus (Mouse Specifics). Mice were recorded walking on the treadmill videography system at 20 cm s −1 . Measures of toe spread (TS) and the print length (PL, distance of the 3rd toe tip to the most posterior paw part) were used to calculate the sciatic nerve functional index (SFI) using the following formula (Baptista et al 2007) :
Tissue preparation and fluorescence imaging
Mice were anesthetized with pentobarbital (100 mg · kg −1 intraperioneal) and fixed by transcardial perfusion with 4% paraformaldehyde dissolved in phosphate buffered saline (PBS). DRG (L3-L5) and sciatic nerves were dissected, postfixed, washed, cryoprotected with sucrose in PBS (30% w/v) for 2-3 d, and frozen (O.C.T., Tissue-Tek). Cryosections of DRG (10 µm thick) and sciatic nerves (10 µm longitudinal sections, 10 µm cross-sections) were blocked with 1% bovine albumin serum (BSA) and 0.1% triton X-100 in PBS for one hour. Sections were incubated with NF200 (1:2000), CGRP (1:500) primary antibody in fresh blocking solution overnight at 4 °C and washed three times (10 min each) in saline. They were then incubated with secondary IgG antibody (1:500, Life Technologies) for one hour at room temperature, washed three times (10 min each) in PBS, and mounted in Vectashield (H-1200). Fluorescein-conjugated GSL I was used at 1:1000. Finally, sciatic nerve cross-sections were incubated with DAPI (1:1000, 15 min, Sigma) and washed in PBS. DRG and sciatic nerve sections were imaged using a Nikon Eclipse 80i microscope using a Nikon 10× objective and Nikon DS-Qi1MC camera. In DRG and sciatic nerves, fluorescence corresponding to tdTomato was absent in tissues from littermate mice that did not express ChR2-tdTomato or that did not express the Cre recombinase.
Results
Functional expression of ChR2 in the PNS
The light-activated ion channel ChR2 was expressed in a broad class of sensory and motor neurons using a Crerecombinase transgenic approach (Campsall et al 2002) ; Cre-dependent ChR2-tdTomato mice were crossed with Thy1-Cre driver mice. The resultant Thy1-Cre::ChR2 mice were heterozygous for both transgenes and ChR2 was found in dorsal root ganglion (DRG) neurons and in sciatic nerve axons (figures 1(A) and (B)). Of the ChR2+ DRG neurons, 41% were myelinated (NF200), 4% were CGRP+ and 5% IB4+. Electrophysiological studies using whole-cell current clamp recordings from ChR2-tdTomato+ DRG neurons showed action potentials were elicited by light ( figure 1(C) ). The large range of membrane capacitances ([11-51] pF; mean 28±4 pF) and thresholds ([−56 to −35] mV; mean −44 ± 2 mV) indicate a broad neuron population was targeted (Browne et al 2017) , as expected for the Thy1 promoter. Functional expression of ChR2 at the mid-axon enables an epineural light-delivery strategy. 
A mouse soft, implantable optical cuff
We designed the optocuff as a soft, tubular construct that can be delicately wrapped around a mouse peripheral nerve, e.g. the sciatic nerve ( figure 2(A) ). Light is delivered to the cuff and the nerve via a flexible optic fiber (105 µm core) subcutaneously threaded from a miniaturized headstage and anchored to the cuff. Multilayers of soft silicones (25 kPa Young's modulus) coated with a reflective thin gold film and a final PDMS film form the 2 mm long, 1 mm diameter cuff ( figure 2(B) ). The reflective metallic coating limits light spill to the surrounding tissues. The soft implant does not compress nor hinder the natural movement of the nerve as its elasticity surpasses that of the nerve (figure 2(C)). We measured blue light transmission in vitro through slices of freshly dissected sciatic nerves. Light is rapidly absorbed with an effective attenuation coefficient µ eff of 3.503 mm −1 at 473 nm tissues ( figure 2(D) ). We measured an average of 16% optical power losses from the optic fiber to the optocuff such that sufficient light power can be delivered at the optocuff to excite opsin-carrying axons. Heating within the optocuff is limited to photon absorption, a significant advantage compared to LED-based optoelectronic interfaces at analogous optical power .
Orderly muscle recruitment to optical stimulation
To measure electromyographic (EMG) responses of anaesthetized Thy1::ChR2 mice to peripheral optical stimulation of motor axons the sciatic nerve of the mouse was exposed and implanted with the optocuff under general anesthesia ( figure  3(A) ). Then, thin EMG electrodes were inserted into the ipsilateral tibialis anterior (TA), an ankle flexor muscle innervated by the peroneal branch of the sciatic nerve. EMG recordings were synchronized with optical stimulation generated by an external 473 nm laser. Short pulses of light consistently triggered unilateral TA contractions, resulting in light-activated twitches. We characterized the muscle recruitment with the peak-to-peak value of EMG signal in the early phase of the response. We found the muscle fibers were recruited in an orderly fashion with the power of epineural irradiance of the optical stimulation (figures 3(B) and (C)). These results suggest more motor units were recruited with higher irradiance stimulation, consequently inducing larger muscle responses. Latency for the EMG onset (mean 6.1 ± 0.3 ms, 60 trials, 10 ms pulse width) was stable relative to the optical stimulation intensity and peak-to-peak amplitude (mean 6.1 ± 0.25 mV), implying direct activation of large and fast motor axons. The TA EMG amplitude directly correlated with optical pulse width ( figure 3(D) ), indicating an increased activation of motor neurons with longer pulses. These results demonstrate peripheral optogenetic modulation in anesthetized mice with the optocuff.
Next, we tested if the soft optocuff affects the sciatic nerve over time. We implanted a group of Thy1-Cre::ChR2 mice for 20 d with an optocuff wrapped around the left sciatic nerve; one end of the optic fiber was permanently anchored to its head-mounted ferrule. Histological cross-section of the nerve at the cuff site did not show any sign of demyelination or signs of inflammation after the prolonged implantation (figures 4(A) and (B)). Coherent with this, sensory and motor behavioral assessments did not reveal any change at various times after implantation. Thermal and mechanical pain-related assays as well as weight bearing and gait were conducted prior and after surgery and did not reveal any significant change (p > 0.05, ANOVA with Dunnett's method).
Epineural stimulation of motor neuron axons in awake mice
Next, we tested whether the optocuff could reliably deliver epineural optical stimulation in awake, freely-behaving mice. We applied epineurally short (2-100 ms) light pulses at 473 nm with the optocuff while continuously monitoring the behavior of Thy1-Cre::ChR2 mice at 1 kHz with a camera (Basler Ace acA2040-180km). Optogenetic stimulation of the Thy1 axons resulted in short latency hindlimb muscle contraction (figures 5(A) and (B), Supp. V1 (stacks.iop.org/ JNE/15/015002/mmedia)). We observed global limb extension and paw opening with short (>5 ms) blue illumination. Probability of behavioural response to optical stimulation was higher with longer pulses (figure 5(C)) and reached 100% for pulses longer than 20 ms. We found the delay for the change in behavior elicited by epineural stimulation was stable through different effective pulse duration (mean 17.9 ± 0.58 ms, figure 5(D) ). Using conduction velocity analysis, we concluded these changes in behavior were elicited by direct activation of motor neurons (Steffens et al 2012) . Furthermore, absence of response to optical stimulation carried with the optocuff in control littermate mice implies that light-responses were not caused by heat or visual artifact. 
Discussion
We have developed an implantable optical interface that enables optogenetic modulation of the PNS in freely-behaving small animals such as mice. The soft optocuff can be wrapped around the sciatic nerve inducing minimal foreign body reaction. Using transgenic Thy1-Cre::ChR2 mice, direct and robust muscle activation was obtained by optical stimulation of axons in the sciatic nerve, both in anaesthetized and awake animals. The muscular response can be finely tuned with the optical stimulation parameters i.e. pulse width and irradiance.
Stable light delivery to neurons/axons in vivo has been challenging, particularly for applications in the spinal cord or peripheral nerves (Montgomery et al 2016) . The relative motion of these soft biological tissues prevent long-term and reliable interface with the stiff implants. Although studies have bypassed this problem by stimulating nerve-endings via transdermal illumination (Daou et al 2013 , Iyer et al 2014 , Arcourt et al 2017 , Browne et al 2017 or using implanted wireless LEDs (Montgomery et al 2015 , Park et al 2015 , interfacing the whole nerve directly offers a broad range of opportunities. We find that reducing the mechanical mismatch between the nerve and implant and optimizing the surgical procedure were key for successful long-term optical coupling with the mouse PNS. The system relies on compliant, subcutaneously tethered fibers that enable a higher intensity and thermally safer light stimulation compared to optoelectronic systems. Additionally, the commercially available external light-sources allow for a large range of solutions for future optogenetic experiments.
Opsin expression in the mouse PNS was achieved using the transgenesis route. Although recent studies have exploited optogenetics in rats or primates (Klein et al 2016 , Pawela et al 2016 , mice are still the predominant species used in the neurobiology field. This animal model presents obvious advantages for genetic manipulations, resulting in a large number of Cre-lines and Cre-dependent viral vectors available. We show that ChR2 opsin expression in PNS neurons was robust enough for optical modulation in vitro and in vivo. The optocuff system can be used for a wide variety of optogenetic experimental approaches, including activation as here and neural inhibition with opsins such as halorhodopsin (NpHr) or archaerhodopsin (Arch). Multi-spectra modulation using multimodal optic fibers will further broaden opportunities for the soft optocuff system (Berndt et al 2014 , Chuong et al 2014 .
Finally, long-term selective modulation of the PNS by light delivery offers new experimental opportunities. Optical stimulation of peripheral axons has great implications for muscle control and nerve regeneration (Liske et al 2013 , Bryson et al 2014 , for the study of sensory biology (Browne et al 2017) and for autonomic output (Kim et al 2015) . Similarly, optogenetic inhibition in vivo will enable to tease out the functional role of specific neurons involve in complex disease mechanisms, such as tactile allodynia following nerve injury (Daou et al 2016) . In summary, soft optocuffs are a simple and efficient tool to probe the PNS with optogenetics. Its manufacturing does not require extensive microfabrication processes. Further miniaturization and addition of a wireless head-mounted light source would allow for an even broader use of the implant, especially to study smaller nerves, such as autonomic and visceral nerves (Birmingham et al 2014) . Finally, the optocuff system supports optogenetics as a versatile tool to unravel the PNS function, an essential step with therapeutic outcomes in many diseases, such as chronic pain.
